| Jeffrey Lubow, MD | |
|
7700 University Dr, West Chester, OH 45069-2505 | |
| (513) 475-8588 | |
| Not Available |
| Full Name | Jeffrey Lubow |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 20 Years |
| Location | 7700 University Dr, West Chester, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467644328 | NPI | - | NPPES |
| 2959508 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 35093815 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Cincinnati Physicians Company Llc | 2264344480 | 1339 |
News Archive
If the eyes are the mirror of the soul, then thanks to the translucent corneas, we can look deep into that soul. And thanks to the work of scientists from the IPC PAS we can look into the depths of the cornea itself.
Food safety experts in Europe have warned that an additive used in some sausages and burgers could cause cancer.
The cause of type 1 diabetes remains unknown. Several studies using immunohistochemistry (IHC) have independently reported hyperexpression of human leukocyte antigen (HLA) class I on pancreatic islet cells in young patients with recent-onset type 1 diabetes. Investigators have therefore suggested that HLA hyperexpression may be an important first step in the development of type 1 diabetes.
Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office has issued a notice of allowance for a patent entitled "Beta-2 microglobulin as a Biomarker for Peripheral Artery Disease."
› Verified 9 days ago
| Entity Name | University Of Cincinnati Physicians Company Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801840434 PECOS PAC ID: 2264344480 Enrollment ID: O20031105000123 |
News Archive
If the eyes are the mirror of the soul, then thanks to the translucent corneas, we can look deep into that soul. And thanks to the work of scientists from the IPC PAS we can look into the depths of the cornea itself.
Food safety experts in Europe have warned that an additive used in some sausages and burgers could cause cancer.
The cause of type 1 diabetes remains unknown. Several studies using immunohistochemistry (IHC) have independently reported hyperexpression of human leukocyte antigen (HLA) class I on pancreatic islet cells in young patients with recent-onset type 1 diabetes. Investigators have therefore suggested that HLA hyperexpression may be an important first step in the development of type 1 diabetes.
Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office has issued a notice of allowance for a patent entitled "Beta-2 microglobulin as a Biomarker for Peripheral Artery Disease."
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Lubow, MD 3200 Burnet Ave, Cincinnati, OH 45229-3019 Ph: () - | Jeffrey Lubow, MD 7700 University Dr, West Chester, OH 45069-2505 Ph: (513) 475-8588 |
News Archive
If the eyes are the mirror of the soul, then thanks to the translucent corneas, we can look deep into that soul. And thanks to the work of scientists from the IPC PAS we can look into the depths of the cornea itself.
Food safety experts in Europe have warned that an additive used in some sausages and burgers could cause cancer.
The cause of type 1 diabetes remains unknown. Several studies using immunohistochemistry (IHC) have independently reported hyperexpression of human leukocyte antigen (HLA) class I on pancreatic islet cells in young patients with recent-onset type 1 diabetes. Investigators have therefore suggested that HLA hyperexpression may be an important first step in the development of type 1 diabetes.
Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office has issued a notice of allowance for a patent entitled "Beta-2 microglobulin as a Biomarker for Peripheral Artery Disease."
› Verified 9 days ago
John Dean Adler, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7675 Wellness Way, 4th Floor, West Chester, OH 45069 Phone: 513-475-8248 Fax: 513-475-7179 | |
James W Buckreus, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7675 Wellness Way, Suite 400, West Chester, OH 45069 Phone: 513-475-8588 Fax: 513-475-4598 | |
Emily G Hurley, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7700 University Dr, West Chester, OH 45069 Phone: 513-475-8248 Fax: 513-475-8468 | |
Fares Alqara, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 7700 University Dr, West Chester, OH 45069 Phone: 513-475-8248 Fax: 513-475-8468 | |
Michael A Thomas, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7675 Wellness Way, West Chester, OH 45069 Phone: 513-475-8588 Fax: 513-475-8267 | |
Shannel R Adams, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7675 Wellness Way Ste 315, West Chester, OH 45069 Phone: 513-475-7657 | |
Mickey M Karram, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7759 University Drive, Suite G, West Chester, OH 45069 Phone: 513-463-2500 Fax: 513-463-2510 |